Design and baseline characteristics of participants in the study of antihypertensive therapy in children and adolescents with autosomal dominant polycystic kidney disease (ADPKD)

Contemporary Clinical Trials

Volumn 26, Issue 2, 2005, Pages 211-222

  Cadnapaphornchai, Melissa A ^a,b   Fick Brosnahan, Godela M ^b   Duley, Irene ^b   Johnson, Ann M ^b   Strain, John D ^c   DeGroff, Curt G ^a   Schrier, Robert W ^b  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL   (United States)

Author keywords

Angiotensin converting enzyme inhibition; Autosomal dominant polycystic kidney disease; Hypertension

Indexed keywords

AMLODIPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROCHLOROTHIAZIDE; LOSARTAN; METOPROLOL;

ADOLESCENT; ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; ENZYME INHIBITION; FEMALE; HUMAN; HYPERTENSION; KIDNEY CYST; KIDNEY POLYCYSTIC DISEASE; MALE; POPULATION RESEARCH; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADOLESCENT; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILD; CHILD, PRESCHOOL; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; MALE; PATIENT SELECTION; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 18844437290     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2005.01.001     Document Type: Article

References (36)

1. G.M. Fick-Brosnahan, T. Ecder, and R. Schrier Polycystic kidney disease R.W. Schrier Diseases of the kidney 2001 Lippincott Williams & Wilkins Philadelphia
2. P.A. Gabow, A.M. Johnson, and W.D. Kaehny Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease Kidney Int. 41 1992 1311 1319
3. P.S. Parfrey, J.C. Bear, and J. Morgan The diagnosis and prognosis of autosomal dominant polycystic kidney disease N. Engl. J. Med. 323 1990 1085 1090
4. D.N. Churchill, J.C. Bear, and J. Morgan Prognosis of adult onset polycystic kidney disease re-evaluated Kidney Int. 26 1984 190 193
5. B.R. Cole, S.B. Conley, and F.B. Stapleton Polycystic kidney disease in the first year of life J. Pediatr. 5 1987 693 699
6. A.B. Chapman, A.M. Johnson, and S. Rainguet Left ventricular hypertrophy in autosomal dominant polycystic kidney disease J. Am. Soc. Nephrol. 8 1997 1292 1297
7. T. Ecder, C.L. Edelstein, and A.B. Chapman Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease Nephrol. Dial. Transplant. 14 1999 1113 1116
8. R. Schrier, K. McFann, and A. Johnson Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study J. Am. Soc. Nephrol. 13 2002 1733 1739
9. A. Bardaji, A.M. Vea, and C. Gutierrez Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease Am. J. Kidney Dis. 32 1998 970 975
10. M. Zeier, S. Geberth, K.G. Schmidt, A. Mendelbaum, and E. Ritz Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease J. Am. Soc. Nephrol. 8 1993 1451 1457
11. D.D. Ivy, E.M. Shaffer, and A.M. Johnson Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease J. Am. Soc. Nephrol. 5 1995 2032 2036
12. G.M. Fick, I.T. Duley, and A.M. Johnson The spectrum of autosomal dominant polycystic kidney disease in children J. Am. Soc. Nephrol. 4 1994 1654 1660
13. T. Seeman, M. Sikut, and M. Konrad Blood pressure and renal function in autosomal dominant polycystic kidney disease Pediatr. Nephrol. 11 1997 592 596
14. G.M. Fick-Brosnahan, Z.V. Tran, A.M. Johnson, J.D. Strain, and P.A. Gabow Progression of autosomal dominant polycystic kidney disease in children Kidney Int. 5 2001 1654 1662
15. P.A. Gabow, I.T. Duley, and A.M. Johnson Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease Am. J. Kidney Dis. 20 1992 140 143
16. P.A. Gabow, W.D. Kaehny, and A.M. Johnson The clinical utility of renal concentrating capacity in polycystic kidney disease Kidney Int. 35 1989 675 680
17. A.B. Chapman, A.M. Johnson, P.A. Gabow, and R.W. Schrier Overt proteinuria and microalbuminuria in autosomal-dominant polycystic kidney disease J. Am. Soc. Nephrol. 5 1994 1349 1354
18. A.B. Chapman, A. Johnson, P.A. Gabow, and R.W. Schrier The renin-angiotensin aldosterone system and autosomal dominant polycystic kidney disease N. Engl. J. Med. 323 1990 1091 1096
19. P.K. Chatterjee, R.P. Weerackody, S.K. Mistry, G.M. Hawksworth, and J.S. McLay Selective antagonism of the AT1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells Kidney Int. 3 1997 699 705
20. M. Ruiz-Ortega, and J. Egido Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts Kidney Int. 6 1997 1497 1510
21. J. Bernstein, A.P. Evan, and K.D. Gardner Jr. Epithelial hyperplasia in human polycystic kidney diseases. Its role in pathogenesis and risk of neoplasia Am. J. Pathol. 1 1987 92 101
22. J.J. Grantham Mechanisms of progression in autosomal dominant polycystic kidney disease Kidney Int., Suppl. 63 1997 S93 S97
23. L.G. Fine, C. Orphanides, and J.T. Norman Progressive renal disease: the chronic hypoxia hypothesis Kidney Int., Suppl. 65 1998 S74 S78
24. M. Zeier, P. Fehrenbach, and S. Geberth Renal histology in polycystic kidney disease with incipient and advanced renal failure Kidney Int. 42 1992 1259 1265
25. J. Gaedeke, N.A. Noble, and W.A. Border Angiotensin II and progressive renal insufficiency Curr. Hypertens Rep. 4 2002 403 407
26. M.I. Phillips, and S. Kagiyama Angiotensin II as a pro-inflammatory mediator Curr. Opin. Investig. Drugs 3 2002 569 577
27. M. Merta, V. Tesar, and T. Zima Cytokine profile in autosomal dominant polycystic kidney disease Biochem. Mol. Biol. Int. 41 1997 619 624
28. A.B. Chapman, L.M. Guay-Woodford, and J.J. Grantham Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort Kidney Int. 64 2003 1035 1045
29. G.J. Schwartz, G.B. Haycock, C.M. Edelmann Jr., and A. Spitzer A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine Pediatrics 2 1976 259 263
30. S. Blumenthal Report of task-force on blood pressure control in children-prepared by National Heart Lung and Blood Institutes Task-force on Blood Pressure Control in Children Pediatrics 59 1977 797 820
31. Report of the 2nd task-force on blood pressure control in children-1987 Pediatrics 79 1987 1 25
32. Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents Pediatrics 98 1996 649 658
33. W.A. Marshall, and J.M. Tanner Variations in pattern of pubertal changes in girls Arch. Dis. Child. 44 1969 291 303
34. S.A. Yarows, and R.D. Brook Measurement variation among 12 electronic home blood pressure monitors Am. J. Hypertens. 13 2000 276 282
35. N.M. Laird, and J.H. Ware Random effects models for longitudinal data Biometrics 4 1982 963 974
36. D. Novick, B. Schwartsburd, and R. Pinkus A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18 Cytokine 14 2001 334 342